A Double-blind, Randomized, Placebo-controlled, Parallel Group, Dose Frequency Study of Ketamine in Subjects With Treatment-resistant Depression
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007296/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to explore the optimal dose frequency of ketamine in patients
with treatment-resistant depression (TRD).
提供机构：
Vivli
创建时间：
2021-07-22
